Continuing to Confront COPD International Surveys: comparison of patient and physician perceptions about COPD risk and management

Abstract

PurposeUsing data from the Continuing to Confront COPD International Physician and Patient Surveys, this paper describes physicians’ attitudes and beliefs regarding chronic obstructive pulmonary disease (COPD) prognosis, and compares physician and patient perceptions with respect to COPD.MethodsIn 12 countries worldwide, 4,343 patients with COPD were identified through systematic screening of population samples, and 1,307 physicians who regularly saw patients with COPD were sampled from in-country professional databases. Both patients and physicians completed surveys about their COPD knowledge, beliefs, and perceptions; physicians answered further questions about diagnostic methods and treatment choices for COPD.ResultsMost physicians (79%) responded that the long-term health outlook for patients with COPD has improved over the past decade, largely attributed to the introduction of better medications. However, patient access to medication remains an issue in many countries, and some physicians (39%) and patients (46%) agreed/strongly agreed with the statement “there are no truly effective treatments for COPD”. There was strong concordance between physicians and patients regarding COPD management practices, including the use of spirometry (86% of physicians and 76% of patients reporting they used/had undergone a spirometry test) and smoking cessation counseling (76% of physicians reported they counseled their smoking patients at every clinic visit, and 71% of smoking patients stated that they had received counseling in the past year). However, the groups differed in their perception about the role of smoking in COPD, with 78% of physicians versus 38% of patients strongly agreeing with the statement “smoking is the cause of most cases of COPD”.ConclusionThe Continuing to Confront COPD International Surveys demonstrate that while physicians and patients largely agreed about COPD management practices and the need for more effective treatments for COPD, a gap exists about the causal role of smoking in COPD.

Lack of awareness towards smoking-related health risks, symptoms related to COPD, and attitudinal factors concerning smoking: an Internet-based survey conducted in a random sample of the Danish general population

“…However, one-third of the smokers in our study disagreed that COPD to a great extent is caused by exposing one-self to risk factors indicating a great lack of knowledge of the main aetiology of COPD. This is supported by the study by Menezes et al [24] reporting that 31% of a cohort of 4343 patients with COPD somewhat disagreed/strongly disagreed that smoking is the cause of most cases of COPD. We found that the smokers feared COPD more than the ex- and never-smokers, but the figures were however low (5.1 vs .…”

A case scenario study for the assessment of physician’s behavior in the management of COPD: the WHY study

“… 16 In a multinational study including centers from the Europe and the United States, 24% of the COPD patients reported that they had not undergone a spirometry test. 17 As can be seen from different population examples, PFTs are not always incorporated in the diagnosis and management of COPD in several parts of the world. The present study showed that spirometry was frequently overlooked in clinical practice in Turkey and that the physicians had problems in interpreting the results when it was performed.…”

Current trends of management of respiratory diseases by pulmonologists: Results of National Conference of Pulmonary Disease - 2015 survey

“…A multinational study conducted in 12 countries also revealed high awareness among treating physicians about COPD management. [1214] The study also showed that for the treatment of COPD (GOLD Stage B), 38% general physicians and 67% of pulmonologists prescribed treatment as per guidelines. [14] In this study, we found that 34.8% of pulmonologists were prescribing treatment as per guidelines, and the patients of GOLD Stage B were being over-treated with ICSs.…”

“…[11] However, similar to our study, 86% of physicians were using spirometry for the diagnosis of COPD in a multinational study conducted in 12 countries. [12] GOLD presently recommends the use of spirometry, which is a reproducible test, for diagnosis and assessment of severity of COPD. The postbronchodilator spirometry values are being used to establish the GOLD stage of the disease and prescribe treatment accordingly.…”